We offer the most innovative solution for acute myocardial infarction (AMI) diagnostics

06 March 2023
Semetron AS

Semetron, in co-operation with device manufacturer Siemens Healthineers, offers the most innovative solution for acute myocardial infarction (AMI) diagnostics – the Atellica® VTL. The device is able to determine high-sensitivity troponin I levels in capillary whole blood in a near-patient setting in just 8 minutes. The Atellica® VTLi wireless device can be easily integrated into the workflow of hospitals and clinics. The new solution will help streamline primary diagnostics in overcrowded emergency care centres.

Vaata lähemalt

More news

Company news
News
SAM IO now available in Estonia

We’re thrilled to announce that SAM IO is now officially... View Article

News
18.07 we are running with reduced staff

Semetron team recharges their batteries and enjoys the summertime together!... View Article

News
Projects
The most modern hospital and health centre in Viljandi parish: Tervikum

Today was the grand opening of the new building of... View Article